Quipt Home Medical Corp.·4

Mar 16, 9:39 AM ET

Bachelder David 4

4 · Quipt Home Medical Corp. · Filed Mar 16, 2026

Research Summary

AI-generated summary of this filing

Updated

Quipt (QIPT) Exec. VP David Bachelder Sells Shares

What Happened
David Bachelder, Executive Vice President of Operations at Quipt Home Medical Corp., disposed of shares on March 16, 2026 as part of a company sale/plan of arrangement. The Form 4 reports a disposition of 22,156 common shares at $3.65 each for $80,869 and two derivative dispositions (50,000 and 30,000 units) reported as N/A on the form. Footnotes to the filing state that all outstanding common shares, RSUs and vested/unvested options were cashed out under the arrangement at US$3.65 per share (less required tax withholdings), implying total gross consideration of approximately $372,869 for the 102,156 shares/units.

Key Details

  • Transaction date: March 16, 2026; reported on Form 4 filed March 16, 2026 (appears timely).
  • Reported trade(s): 22,156 common shares sold at $3.65 for $80,869; 50,000 and 30,000 derivative units (RSUs/options) disposed — Form lists N/A for per-unit price/value for these derivative items.
  • Post-transaction holdings: the filing does not state a remaining share count; footnotes indicate all Shares were deemed transferred to the purchaser under the arrangement.
  • Notable footnotes: (F1) Purchasers 1567208 B.C. LTD and REM Aggregator acquired all issued shares for US$3.65/share; (F2) RSUs were cashed out at US$3.65 each (less tax withholding); (F3) Options were vested/settled for the excess of US$3.65 over exercise price (options with exercise price ≥ US$3.65 cancelled).
  • Tax/withholding: cash consideration subject to required tax withholding per footnotes.

Context
These were not open-market sales but a cash-out of equity due to a going-private/arrangement transaction—common in acquisitions and not an ordinary insider sale reflecting trading sentiment. The derivative entries reflect RSUs/options being converted to cash under the deal rather than separate option exercises or market trades.

Insider Transaction Report

Form 4Exit
Period: 2026-03-16
Bachelder David
Exec. VP Operations
Transactions
  • Disposition to Issuer

    Common Shares

    [F1][F2]
    2026-03-16$3.65/sh22,156$80,8690 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    [F3]
    2026-03-1650,0000 total
    Exercise: $4.99Common Shares (50,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    [F3]
    2026-03-1630,0000 total
    Exercise: $6.14Common Shares (30,000 underlying)
Footnotes (3)
  • [F1]On March 16, 2026, 1567208 B.C. LTD, a company existing under the laws of British Columbia ("B.C. Purchaser"), and REM Aggregator, LLC, a Delaware limited liability company (individually, "REM Aggregator", and collectively with B.C. Purchaser ("Purchaser" or "Purchasers") acquired all of the issued and outstanding common shares (the "Shares") of Issuer under a plan of arrangement (the "Arrangement Agreement") pursuant to the Business Corporations Act (British Columbia) (the "BCBCA"). At the Effective Time (the "Effective Time") of the Arrangement Agreement each Share, other than any Shares held by shareholders who may properly exercised dissent rights under the BCBCA ("Dissenting Shareholders"), were deemed to be transferred to Purchaser in consideration for the right to receive a cash payment from the Purchaser in the amount equal to US$3.65, without interest.
  • [F2]The Shares include restricted share units ("RSUs"), which RSUs outstanding immediately prior to the Effective Time (whether vested or unvested) were, without any further action by or on behalf of the holder of any such RSU, deemed to be transferred by such holder to Issuer in consideration for the right to receive a cash payment from Issuer in the amount equal to US$3.65, less any amounts Issuer is required to withhold for taxes, without interest. Each RSU is the economic equivalent of one Share.
  • [F3]Pursuant to the terms of the Arrangement Agreement, immediately following the Effective Time, each option exercisable to acquire one or more Shares from the Issuer (an "Option"), outstanding immediately prior to the Effective Time (whether vested or unvested) were deemed to be unconditionally vested and exercisable and will, without any further action by or on behalf of a holder of the Option, deemed to be surrendered and transferred by such holder to the Issuer in consideration for the right to receive a cash payment from the Issuer in an amount equal to the excess, if any, of US$3.65 over the exercise price of such option, less any amounts the Issuer is required to withhold for taxes, without interest. Any option for which the exercise price is equal to or greater than US$3.65 will be cancelled for no consideration.
Signature
/s/ David Bachelder|2026-03-16

Documents

1 file
  • 4
    tm268640-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT